Rixin Zhou

518 total citations
13 papers, 413 citations indexed

About

Rixin Zhou is a scholar working on Molecular Biology, Cell Biology and Computer Vision and Pattern Recognition. According to data from OpenAlex, Rixin Zhou has authored 13 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Cell Biology and 3 papers in Computer Vision and Pattern Recognition. Recurrent topics in Rixin Zhou's work include MicroRNA in disease regulation (2 papers), Cellular Mechanics and Interactions (2 papers) and Ubiquitin and proteasome pathways (2 papers). Rixin Zhou is often cited by papers focused on MicroRNA in disease regulation (2 papers), Cellular Mechanics and Interactions (2 papers) and Ubiquitin and proteasome pathways (2 papers). Rixin Zhou collaborates with scholars based in United States, China and Poland. Rixin Zhou's co-authors include Charles M. Rudin, Omar Skalli, David James VanderWeele, Matthew G. Vander Heiden, Maria Guarnera, Jian Su, Feng Jiang, Lingxiao Xing, Sanford A. Stass and Ling Cai and has published in prestigious journals such as Clinical Cancer Research, American Journal Of Pathology and Experimental Cell Research.

In The Last Decade

Rixin Zhou

13 papers receiving 408 citations

Peers

Rixin Zhou
Teresita Reiner United States
Roseanne S. Wexler United States
Marika A. Russo United States
Cassandra L. Buchheit United States
Alireza Alavi United States
Qinhui Song United States
Rixin Zhou
Citations per year, relative to Rixin Zhou Rixin Zhou (= 1×) peers Petra Ohneseit

Countries citing papers authored by Rixin Zhou

Since Specialization
Citations

This map shows the geographic impact of Rixin Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rixin Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rixin Zhou more than expected).

Fields of papers citing papers by Rixin Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rixin Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rixin Zhou. The network helps show where Rixin Zhou may publish in the future.

Co-authorship network of co-authors of Rixin Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Rixin Zhou. A scholar is included among the top collaborators of Rixin Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rixin Zhou. Rixin Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Zhou, Rixin, et al.. (2024). Detecting oracle bone inscriptions via pseudo-category labels. Heritage Science. 12(1). 8 indexed citations
2.
Du, Wei, et al.. (2024). Consistency label-activated region generating network for weakly supervised medical image segmentation. Computers in Biology and Medicine. 173. 108380–108380. 1 indexed citations
4.
Ali, Ahmad H., et al.. (2017). The Effect of Perioperative Cimetidine Administration on Time to Colorectal Cancer Recurrence. American Journal of Therapeutics. 25(4). e405–e411. 8 indexed citations
5.
Xing, Lingxiao, Jian Su, Maria Guarnera, et al.. (2015). Sputum microRNA Biomarkers for Identifying Lung Cancer in Indeterminate Solitary Pulmonary Nodules. Clinical Cancer Research. 21(2). 484–489. 87 indexed citations
6.
VanderWeele, David James, Rixin Zhou, & Charles M. Rudin. (2004). Akt up-regulation increases resistance to microtubule-directed chemotherapeutic agents through mammalian target of rapamycin. Molecular Cancer Therapeutics. 3(12). 1605–1613. 92 indexed citations
7.
Zhou, Rixin, et al.. (2002). The Hyaluronan Receptor RHAMM/IHABP in Astrocytoma Cells: Expression of a Tumor-specific Variant and Association with Microtubules. Journal of Neuro-Oncology. 59(1). 15–26. 13 indexed citations
8.
Huang, Charles, Rixin Zhou, David C.H. Yang, & P Boon Chock. (2002). Application of the continuous variation method to cooperative interactions: mechanism of Fe(II)–ferrozine chelation and conditions leading to anomalous binding ratios. Biophysical Chemistry. 100(1-3). 143–149. 39 indexed citations
9.
Zhou, Rixin, Matthew G. Vander Heiden, & Charles M. Rudin. (2002). Genotoxic exposure is associated with alterations in glucose uptake and metabolism.. PubMed. 62(12). 3515–20. 56 indexed citations
10.
Zhou, Rixin, et al.. (2001). TGF-α induces a stationary, radial-glia like phenotype in cultured astrocytes. Brain Research Bulletin. 56(1). 37–42. 21 indexed citations
11.
Zhou, Rixin & Omar Skalli. (2000). TGF-α Differentially Regulates GFAP, Vimentin, and Nestin Gene Expression in U-373 MG Glioblastoma Cells: Correlation with Cell Shape and Motility. Experimental Cell Research. 254(2). 269–278. 36 indexed citations
12.
Zhou, Rixin & Omar Skalli. (2000). Identification of cadherin-11 down-regulation as a common response of astrocytoma cells to Transforming Growth Factor-α. Differentiation. 66(4-5). 165–172. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026